SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-016946
Filing Date
2024-04-19
Accepted
2024-04-19 16:07:07
Documents
4
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A fy2023proxystatement.htm PRE 14A 513643
2 image_0.jpg GRAPHIC 6694
3 imagea.jpg GRAPHIC 74857
4 proxycard.jpg GRAPHIC 69091
  Complete submission text file 0001628280-24-016946.txt   722521
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41536 | Film No.: 24857803
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)